Search research articles
Contact Us
Filters
Showing results (141-150 of 151) with videos related to
Page
of 16
Sort By:
Transplantation Direct
|
December 20, 2016
Identification of Novel and Noninvasive Biomarkers of Acute Cellular Rejection After Liver Transplantation by Protein Microarray
Keita Okubo, Hiroshi Wada, Atsushi Tanaka, et al.
Surgical Case Reports
|
October 23, 2024
An aggressive gastric CIC-DUX4 sarcoma surgically resected with multivisceral organs: a case report
Mizuki Koba, Atsushi Takeno, Hiroko Hasegawa, et al.
The Journal of Biological Chemistry
|
July 12, 2014
Interferon-α acts on the S/G2/M phases to induce apoptosis in the G1 phase of an IFNAR2-expressing hepatocellular carcinoma cell line
Sakae Maeda, Hiroshi Wada, Yoko Naito, et al.
International Immunology
|
December 24, 2019
Interleukin-34 expression in ovarian cancer: a possible correlation with disease progression
Hiraku Endo, Naoki Hama, Muhammad Baghdadi, et al.
Clinical Journal of Gastroenterology
|
March 10, 2021
Retrograde endoscopic submucosal dissection for early thoracic esophageal carcinoma
Yuta Kobayashi, Kazuhiro Nishikawa, Tomofumi Akasaka, et al.
Oncology Letters
|
January 2, 2016
Cyclin G2: A novel independent prognostic marker in pancreatic cancer
Shinichiro Hasegawa, Hiroaki Nagano, Masamitsu Konno, et al.
Trials
|
August 27, 2021
Randomized phase II study of gemcitabine and S-1 combination therapy versus gemcitabine and nanoparticle albumin-bound paclitaxel combination therapy as neoadjuvant chemotherapy for resectable/borderline resectable pancreatic ductal adenocarcinoma (PDAC-GS/GA-rP2, CSGO-HBP-015)
Daisaku Yamada, Shogo Kobayashi, Hidenori Takahashi, et al.
Plos One
|
March 26, 2026
Study protocol: A randomized controlled trial of chemoradiotherapy versus chemotherapy as neoadjuvant therapy for resectable pancreatic cancer (CSGO-HBP-027)
Yoshito Tomimaru, Hirofumi Akita, Keisuke Tamari, et al.
Pancreas
|
July 25, 2014
Clinicopathological Significance of Leucine-Rich α2-Glycoprotein-1 in Sera of Patients With Pancreatic Cancer
Kenta Furukawa, Koichi Kawamoto, Hidetoshi Eguchi, et al.
Internal Medicine (Tokyo, Japan)
|
April 3, 2015
Solitary fibrous tumor of the liver from development to resection
Yuki Makino, Masanori Miyazaki, Minoru Shigekawa, et al.
Page
of 16
Search research articles
Search
Showing results (141-150 of 151) with videos related to
Sort By:
Page
of 16
Transplantation Direct
|
December 20, 2016
Identification of Novel and Noninvasive Biomarkers of Acute Cellular Rejection After Liver Transplantation by Protein Microarray
Keita Okubo, Hiroshi Wada, Atsushi Tanaka, et al.
Surgical Case Reports
|
October 23, 2024
An aggressive gastric CIC-DUX4 sarcoma surgically resected with multivisceral organs: a case report
Mizuki Koba, Atsushi Takeno, Hiroko Hasegawa, et al.
The Journal of Biological Chemistry
|
July 12, 2014
Interferon-α acts on the S/G2/M phases to induce apoptosis in the G1 phase of an IFNAR2-expressing hepatocellular carcinoma cell line
Sakae Maeda, Hiroshi Wada, Yoko Naito, et al.
International Immunology
|
December 24, 2019
Interleukin-34 expression in ovarian cancer: a possible correlation with disease progression
Hiraku Endo, Naoki Hama, Muhammad Baghdadi, et al.
Clinical Journal of Gastroenterology
|
March 10, 2021
Retrograde endoscopic submucosal dissection for early thoracic esophageal carcinoma
Yuta Kobayashi, Kazuhiro Nishikawa, Tomofumi Akasaka, et al.
Oncology Letters
|
January 2, 2016
Cyclin G2: A novel independent prognostic marker in pancreatic cancer
Shinichiro Hasegawa, Hiroaki Nagano, Masamitsu Konno, et al.
Trials
|
August 27, 2021
Randomized phase II study of gemcitabine and S-1 combination therapy versus gemcitabine and nanoparticle albumin-bound paclitaxel combination therapy as neoadjuvant chemotherapy for resectable/borderline resectable pancreatic ductal adenocarcinoma (PDAC-GS/GA-rP2, CSGO-HBP-015)
Daisaku Yamada, Shogo Kobayashi, Hidenori Takahashi, et al.
Plos One
|
March 26, 2026
Study protocol: A randomized controlled trial of chemoradiotherapy versus chemotherapy as neoadjuvant therapy for resectable pancreatic cancer (CSGO-HBP-027)
Yoshito Tomimaru, Hirofumi Akita, Keisuke Tamari, et al.
Pancreas
|
July 25, 2014
Clinicopathological Significance of Leucine-Rich α2-Glycoprotein-1 in Sera of Patients With Pancreatic Cancer
Kenta Furukawa, Koichi Kawamoto, Hidetoshi Eguchi, et al.
Internal Medicine (Tokyo, Japan)
|
April 3, 2015
Solitary fibrous tumor of the liver from development to resection
Yuki Makino, Masanori Miyazaki, Minoru Shigekawa, et al.
Page
of 16